IV
Inventiva S.A.
IVEVF · OTC
$3.59 +0.00% (+$0.00)
Market Cap 734.1M €
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 163.82x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 28.34%
FCF growth N/A
Book val. growth N/A
Profitability
14 /100
Weak Net margin 7,899.58%
Op. margin 2,965.26%
FCF margin 2,345.98%
Quality
0 /100
Poor ROA 141.88%
Asset turnover 0.02x
ROIC 64.58%
Debt
43 /100
Moderate Int. coverage -4.06x
Current ratio 3.16x
Net debt/EBITDA N/A
Stability
32 /100
Unstable Rev. volatility 56.55%
EPS volatility 61.93%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na IVEVF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Andrew Obenshain
Employees
77
Headquarters
Daix
Nadcházející události
28 ZÁŘ
Earnings
Upcoming earnings report